2-(cyclobutadienyl)-4-(6-oxo-1H-pyridin-3-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile
C20H17N3O — CID 90041921
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(cyclobutadienyl)-4-(6-oxo-1H-pyridin-3-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile
2-(cyclobutadienyl)-4-(6-oxo-1H-pyridin-3-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile (PubChem CID 90041921) has the molecular formula C20H17N3O and a molecular weight of 315.38 g/mol. Its IUPAC name is 2-(cyclobutadienyl)-4-(6-oxo-1H-pyridin-3-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 2-(cyclobutadienyl)-4-(6-oxo-1H-pyridin-3-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 90041921 |
| Molecular Formula | C20H17N3O |
| Molecular Weight | 315.38 g/mol |
| Exact Mass | 315.14 |
| IUPAC Name | 2-(cyclobutadienyl)-4-(6-oxo-1H-pyridin-3-yl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridine-3-carbonitrile |
| SMILES | N#Cc1c(C2=CC=C2)nc2c(c1-c1ccc(=O)[nH]c1)CCCCC2 |
| InChI | InChI=1S/C20H17N3O/c21-11-16-19(14-9-10-18(24)22-12-14)15-7-2-1-3-8-17(15)23-20(16)13-5-4-6-13/h4-6,9-10,12H,1-3,7-8H2,(H,22,24) |
| InChIKey | PXFKLRLISNUOFQ-UHFFFAOYSA-N |
| XLogP | 3.53 |
| TPSA | 69.54 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 315.38 |
| LogP ≤ 5 | 3.53 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90041921 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.